That this House recognises the importance of World Tuberculosis Day on 24 March 2010; notes with concern the continued rise in tuberculosis (TB) cases globally, resulting in nearly 5,000 deaths a day and the increase of TB in the UK, particularly among vulnerable, marginalised populations; further notes that TB-HIV co-infection and TB drug resistance is fuelling the epidemic; and calls on the Government to ensure the maximum effectiveness is achieved through its efforts in the UK and overseas to combat this preventable and curable disease.

That this House recognises the importance of World Tuberculosis Day on 24 March 2010; notes with concern the continued rise in tuberculosis (TB) cases globally, resulting in nearly 5,000 deaths a day and the increase of TB in the UK, particularly among vulnerable, marginalised populations; further notes that TB-HIV co-infection...

That this House welcomes the third International Rare Disease Day on 28 February 2010; notes that there are over 6,000 rare diseases, affecting approximately 3.5 million people in the UK; supports the focus of this year's Rare Disease Day on the importance of research into rare diseases for the millions of patients without a cure; believes that rare diseases should be seen as a public health priority; and joins Rare Disease UK in calling on the Government to act on its commitment to a strategy for rare diseases as demonstrated by the adoption of the European Council Recommendation on action for rare diseases in June 2009.

That this House welcomes the third International Rare Disease Day on 28 February 2010; notes that there are over 6,000 rare diseases, affecting approximately 3.5 million people in the UK; supports the focus of this year's Rare Disease Day on the importance of research into rare diseases for the millions...

That this House congratulates the MS Society on its campaign to uphold the rights of people living with multiple sclerosis, namely the right to quality health care including fair access to appropriate drugs and treatments, the right to personalised care and support, the right to wheelchairs and equipment to enable independent living and the right to support in and out of work, including support for carers; and commends the MS Society for its success in highlighting the impact of this unpredictable and incurable condition.

That this House congratulates the MS Society on its campaign to uphold the rights of people living with multiple sclerosis, namely the right to quality health care including fair access to appropriate drugs and treatments, the right to personalised care and support, the right to wheelchairs and equipment to enable...

That this House expresses concern that under 18 year olds are able to access easily unsupervised sunbed salons; further expresses strong concern that malignant melanoma, the most dangerous form of skin cancer, is increasing at an alarming rate across the UK; notes with concern that the International Agency for Research on Cancer has re-classified sunbeds into its highest cancer risk category alongside tobacco; further notes research commissioned by Cancer Research UK found that in 2008-09 six per cent. of 11 to 17 year olds have used sunbeds; further notes that the research also found that 50 per cent. of 15 to 17 year old girls in Liverpool and Sunderland have used a sunbed; recognises that 87 per cent. of the UK public believe under 18 year olds should not use sunbeds, with 90 per cent. supporting sunbed salons being staffed; welcomes the private Member's Sunbed (Regulation) Bill which would make it an offence for an operator to allow under-18s to use sunbeds; and calls on hon. Members of both Houses to support legislation to protect children from sunbeds.

That this House expresses concern that under 18 year olds are able to access easily unsupervised sunbed salons; further expresses strong concern that malignant melanoma, the most dangerous form of skin cancer, is increasing at an alarming rate across the UK; notes with concern that the International Agency for Research...

That this House most warmly welcomes the Contaminated Blood (Support for Infected and Bereaved Persons) Bill [Lords] with its provisions for the relief of privation for those afflicted and bereaved through treatment with contaminated NHS blood and blood products; and calls on the Government and hon. Members of all parties and of none to ensure this humane Bill's passage into law in this session of Parliament.

That this House most warmly welcomes the Contaminated Blood (Support for Infected and Bereaved Persons) Bill [Lords] with its provisions for the relief of privation for those afflicted and bereaved through treatment with contaminated NHS blood and blood products; and calls on the Government and hon. Members of all parties...

That this House accepts expert evidence that pleural plaques represent a change to the anatomy of the sufferer evidenced by the abnormal scarring caused by the permanent physical penetration of asbestos fibres; believes the Law Lords ruling that physiological damage as well as anatomical damage is necessary for an injury to constitute actionable damage is clearly inconsistent with other areas of personal injury; notes that many sufferers of the condition would receive compensation if the scarring was on the outside of the body; and calls on the Secretary of State for Justice to restore the status quo ante to allay the strong sense of injustice felt by sufferers who have sustained asbestos exposure through their employers' negligence and have been unable to proceed with a court action since the Law Lords decision of October 2007.

That this House accepts expert evidence that pleural plaques represent a change to the anatomy of the sufferer evidenced by the abnormal scarring caused by the permanent physical penetration of asbestos fibres; believes the Law Lords ruling that physiological damage as well as anatomical damage is necessary for an injury...

That this House endorses the call by the Motor Neurone Disease Association for a national strategy for motor neurone disease (MND) and believes that such a strategy would lead to enhanced cost-effectiveness and good practice; supports the implementation of the National Service Framework for Long-Term Neurological Conditions; is dismayed that no official national clinical guidance or approach exists in relation to MND; notes the extreme cruelty of motor neurone disease, which dramatically curtails lives and traps an often healthy mind in a failing and incapacitated body; and further believes that a national strategy is urgently needed in order to address the inequity of access to best practice in care for people with MND and to ensure as high a quality of life as possible and dignity in death.

That this House endorses the call by the Motor Neurone Disease Association for a national strategy for motor neurone disease (MND) and believes that such a strategy would lead to enhanced cost-effectiveness and good practice; supports the implementation of the National Service Framework for Long-Term Neurological Conditions; is dismayed that...

That this House celebrate World Chronic Obstructive Pulmonary Disease (COPD) Day on 18 November 2009; eagerly awaits the forthcoming clinical strategy for COPD; understands that if fully implemented this 10-year plan for the NHS will raise the quality of care for people living with COPD, address the lack of awareness of the condition and help to identify the millions of people with undiagnosed COPD; supports the aim of the British Lung Foundation to make COPD a disease of the past by ensuring that people are diagnosed during the early stages of their disease and are encouraged to take steps that will halt the disease progression; and endorses the award-winning Love Your Lungs campaign led by the British Lung Foundation which uses demographic data to identify where people with undiagnosed COPD are most likely to live and which through targeted campaigning encourages people most at risk to have a lung function test.

That this House celebrate World Chronic Obstructive Pulmonary Disease (COPD) Day on 18 November 2009; eagerly awaits the forthcoming clinical strategy for COPD; understands that if fully implemented this 10-year plan for the NHS will raise the quality of care for people living with COPD, address the lack of awareness...

That this House notes that malaria still afflicts 40 per cent. of the world's population; calls on governments of malaria-endemic countries and international public and private organisations to work together to fight malaria worldwide and to raise awareness of malaria; further notes that, although preventable and curable, malaria continues to infect more than 500 million people each year in more than 90 countries of the world, killing betweenone and three million people, including a child every 30 seconds, and that it is especially lethal to children underfive and pregnant mothers;further notes that although the burden of malaria is heaviest in sub-Saharan Africa, it also afflicts Asia, Latin America, the Middle East and parts of Europe, and is spreading with climate change; congratulates all those engaged in the global campaign against malaria; further notes a number of countries have reduced malaria deaths by 50 per cent. in the last five years as theresources and implementation of preventative measures and treatments have been scaled up;further notes thatmalaria will only be defeated through collaboration and co-ordinated action of all relevant actors on local, national, regional and international levels; and therefore calls on the Government to maintain and enhance its international co-operation, collaboration and co-ordination of action towards the achievement of the UN 2010 and 2015 goals to end suffering and deaths from malaria, the world's most avoidable but devastating scourge.

That this House notes that malaria still afflicts 40 per cent. of the world's population; calls on governments of malaria-endemic countries and international public and private organisations to work together to fight malaria worldwide and to raise awareness of malaria; further notes that, although preventable and curable, malaria continues to...

That this House notes the 171 deaths and confirmed cases of variant Creutzfeldt-Jakob Disease (vCJD) and the four currently surviving victims of the disease in the UK, including four through blood transfusion compared with three in total in the US; congratulates and welcomes the work of Christine Lord, following the tragic death of her son Andy from vCJD at the age of 24, in establishing a website, www.justiceforandy.com, and producing a BBC South documentary Who Killed My Son; asks the BBC to screen the documentary nationwide; further asks the Government to commission further research to establish common factors, such as school catering and vaccines among vCJD victims in South Hampshire as well as elsewhere in the country including the cases of two young men from Eastleigh near Southampton who died of vCJD within weeks of each other, and who had both received polio vaccines from the same batch; further notes the Written Answer from the Minister of State for Health on 11 March 2008, giving a vCJD sub-clinical prevalence estimate of up to one in 1,400 of the population; and further asks that the Government completes its evaluation of screening for prions in blood supply and other possible measures to protect the blood supply, in light of the conclusions reported in the 15th annual report of the National Creutzfeldt-Jakob Disease Surveillance Unit, that blood transfusion is the most effective transmission route for vCJD.

That this House notes the 171 deaths and confirmed cases of variant Creutzfeldt-Jakob Disease (vCJD) and the four currently surviving victims of the disease in the UK, including four through blood transfusion compared with three in total in the US; congratulates and welcomes the work of Christine Lord, following the...

That this House accepts expert evidence that pleural plaques represent a change to the anatomy of the sufferer evidenced by the abnormal scarring caused by the permanent physical penetration of asbestos fibres; believes the Law Lords ruling that physiological damage as well as anatomical damage is necessary for an injury to constitute actionable damage is clearly inconsistent with other areas of personal injury; notes that many sufferers of the condition would receive compensation if the scarring was on the outside of the body; and calls on the Secretary of State for Justice to restore the status quo ante to allay the strong sense of injustice felt by sufferers who have sustained asbestos exposure through their employers' negligence and have been unable to proceed with a court action since the Law Lords decision of October 2007.

That this House accepts expert evidence that pleural plaques represent a change to the anatomy of the sufferer evidenced by the abnormal scarring caused by the permanent physical penetration of asbestos fibres; believes the Law Lords ruling that physiological damage as well as anatomical damage is necessary for an injury...

That this House supports the first International World Pneumonia Day, on 2 November 2009; notes that the inaugural World Pneumonia Day is being marked by an event at the House of Commons in London on 28 October 2009; congratulates the organisers of events in New York, Bangladesh, Nigeria, Kenya, Uganda, Australia and other countries to highlight the scourge of pneumonia which kills more than four million people every year, half of whom are children under the age of five years; supports the Global Coalition Against Pneumonia, which includes the Global Alliance for Vaccines and Immunisations Alliance, PneumoADIP, Save the Children, Hedge Funds against Malaria and Pneumonia and other partners who have organised and helped promote World Pneumonia Day; hopes that World Pneumonia Day will encourage further support in the fight against pneumonia in the developing and developed world; further congratulates the Government for its role to date in supporting the Advanced Market Commitment for pneumococcal disease, the leading cause of pneumonia deaths; and calls on the Government to give continuing support to combat this terrible disease which claims the life of a child every 15 seconds.

That this House supports the first International World Pneumonia Day, on 2 November 2009; notes that the inaugural World Pneumonia Day is being marked by an event at the House of Commons in London on 28 October 2009; congratulates the organisers of events in New York, Bangladesh, Nigeria, Kenya, Uganda,...

That this House is aware that asbestos victims around the country were affronted by the 2007 Law Lords' judgement that people suffering with pleural plaques should no longer be compensated; and notes that on 28 October 2009 there will be a combined Union of Construction, Allied Trades and Technicians, GMB Unite, Unison, TUC and Asbestos Groups' lobby of Parliament to urge the Secretary of State for Justice to restore the rights of victims to seek compensation in the courts.

That this House is aware that asbestos victims around the country were affronted by the 2007 Law Lords' judgement that people suffering with pleural plaques should no longer be compensated; and notes that on 28 October 2009 there will be a combined Union of Construction, Allied Trades and Technicians, GMB...

That this House recognises that over 45,500 women and around 300 men in the United Kingdom will be diagnosed with breast cancer in 2009; endorses Breast Cancer Campaign's Wear It Pink on 30 October 2009; notes the importance of the event in promoting awareness of breast cancer among the general public; encourages hon. Members to participate in the initiative to help raise funds for innovative world-class breast cancer research at centres of excellence throughout the UK; and congratulates Breast Cancer Campaign and all of its supporters for having raised over ??3.5 million in 2008 through Wear It Pink.

That this House recognises that over 45,500 women and around 300 men in the United Kingdom will be diagnosed with breast cancer in 2009; endorses Breast Cancer Campaign's Wear It Pink on 30 October 2009; notes the importance of the event in promoting awareness of breast cancer among the general...

That this House welcomes the launch of the East of England Muscle Group; notes that the new group is led by local families and people affected by muscular dystrophy and related neuromuscular conditions who will campaign to improve access to essential specialist care and support; is concerned to learn of the serious problems affecting the 5,500 people with muscular dystrophy and related neuromuscular conditions living in the East of England; further notes that access to multi-disciplinary specialist care improves overall health outcomes and survival for patients with muscular dystrophy and related neuromuscular conditions; is deeply concerned that some patients are being denied access to multi-disciplinary specialist care; calls on the East of England Specialised Commissioning Group, local primary care trusts and the Strategic Health Authority to take forward a review of neuromuscular services which will identify areas of best practice and gaps in NHS service provision; and praises the campaign led by the Muscular Dystrophy Campaign, local families, health professionals and experts in these conditions who will work together to fight for good access to clinically effective, first class, specialised neuromuscular services across the East of England region.

That this House welcomes the launch of the East of England Muscle Group; notes that the new group is led by local families and people affected by muscular dystrophy and related neuromuscular conditions who will campaign to improve access to essential specialist care and support; is concerned to learn of...

That this House welcomes the findings of the All Party Parliamentary Group for Parkinson's Disease inquiry into health and social care, which concludes that there are systemic problems with access to key services for people with Parkinson's and their carers throughout England, Wales and Northern Ireland; endorses its recommendations, including that the Department of Health should hold a five-year review of progress towards implementation of the National Service Framework for Long-term (Neurological) Conditions; believes that there is a pressing need for stronger national leadership on neurological services in England, Wales and Northern Ireland; and further welcomes the newly launched Fair Care for Parkinson's campaign by the Parkinson's Disease Society, which aims to improve services for people affected by the condition.

That this House welcomes the findings of the All Party Parliamentary Group for Parkinson's Disease inquiry into health and social care, which concludes that there are systemic problems with access to key services for people with Parkinson's and their carers throughout England, Wales and Northern Ireland; endorses its recommendations, including...

That this House notes with concern that around the world 15 million children have lost one or more parents due to AIDS; notes that only 31 per cent. of adults and barely 10 per cent. of children in need of HIV treatment have access to it and that access to prevention is also limited; further notes that there is a lack of appropriate HIV treatments for children, and that the number of adults who have become resistant to basic HIV treatment and require more expensive medicines is increasing; recognises that pharmaceutical companies have a vital role to play in helping to achieve universal access to prevention, treatment, care and support by 2010; welcomes the fact that many companies have chosen voluntarily to sign up to new patent pool arrangements; and calls for governments, businesses and voluntary organisations to work together in tackling the epidemic.

That this House notes with concern that around the world 15 million children have lost one or more parents due to AIDS; notes that only 31 per cent. of adults and barely 10 per cent. of children in need of HIV treatment have access to it and that access to...